Septic Bursitis - Olecranon and Prepatellar

Key Points

• Staphylococcus aureus is the most common pathogen in septic olecranon and prepatellar bursitis.
• Preserved passive joint motion favors bursitis over septic arthritis but does not completely exclude deeper infection.
• Aspirate when diagnosis is uncertain, illness is severe, crystal disease is plausible, or microbiology will change management.
• Send aspirated fluid for culture and crystals; no single bursal fluid white-cell threshold is definitive.
• Empiric antibiotics should cover staphylococci and streptococci, with MRSA coverage based on local risk.
• Admit patients with systemic toxicity, severe cellulitis, immunocompromise, oral treatment failure, or unsafe follow-up.
• Recurrent pressure and minor skin trauma should be addressed to reduce recurrence.
• Failure to improve should prompt reassessment for abscess, septic arthritis, osteomyelitis, resistant organisms, or need for surgery.

Algorithm

1. Confirm swelling is centered over a superficial bursa and assess adjacent joint motion, cellulitis, wound, and systemic illness.
2. Use ultrasound when the presence or extent of bursal fluid is uncertain.
3. Aspirate when diagnosis or severity warrants and send cell count, Gram stain, culture, and crystal analysis.
4. Start empiric antistaphylococcal and streptococcal antibiotics, adding MRSA coverage according to risk and local susceptibility.
5. Treat stable uncomplicated cases orally with close follow-up; admit severe or high-risk cases for IV therapy.
6. Protect the bursa from pressure and provide analgesia.
7. Reassess promptly; pursue repeat drainage or surgical consultation for persistent collection or treatment failure.

Clinical Synopsis & Reasoning

Septic bursitis presents with localized swelling, warmth, erythema, and tenderness over a superficial bursa, most commonly the olecranon or prepatellar bursa. Fever may be absent. Minor trauma, repetitive pressure, abrasions, gout, diabetes, immunosuppression, and occupational kneeling or elbow pressure increase risk. The key diagnostic distinction is between infection confined to the bursa and septic arthritis involving the adjacent joint. Patients with bursitis often retain substantially more passive joint motion than patients with septic arthritis, although pain and swelling can still limit movement.

Examine the entire limb for cellulitis, lymphangitis, penetrating injury, abscess, joint effusion, and distal neurovascular abnormalities. Mark the border of erythema when progression is a concern. Point-of-care ultrasound can confirm a fluid-filled bursa, distinguish cellulitis from a drainable collection, and help guide aspiration. Aspiration is most useful when the diagnosis is uncertain, the patient is immunocompromised or systemically ill, crystal disease is plausible, or culture will materially guide therapy. Send bursal fluid for cell count with differential, Gram stain, culture, and crystal analysis when aspirated. No single cell-count cutoff perfectly separates septic from aseptic bursitis.

Avoid passing a needle directly through overlying infected skin if a safer approach into the bursa is available. Routine aspiration of clearly noninfectious microtraumatic bursitis can introduce infection and is generally avoided. Blood cultures are reasonable in severe systemic illness but are not required in every uncomplicated case. Plain radiographs are usually low yield unless fracture, foreign body, osteomyelitis, or calcification is suspected.

Treatment Strategy & Disposition

Empiric therapy should cover Staphylococcus aureus and streptococci. For a stable patient with mild to moderate disease who can adhere to follow-up, oral therapy may be appropriate. Options are chosen according to local susceptibility patterns and MRSA risk. Cephalexin or dicloxacillin may be used when methicillin-sensitive staphylococci are likely; doxycycline or trimethoprim-sulfamethoxazole can provide MRSA activity but may need accompanying streptococcal coverage depending on the clinical setting. Severe infection, systemic toxicity, rapidly spreading cellulitis, immunocompromise, inability to tolerate oral therapy, or unreliable follow-up favors admission and IV treatment such as vancomycin while cultures are pending.

Rest the affected area, avoid repetitive pressure, use protective padding, and provide analgesia. Compression may be used cautiously when tolerated. Repeated aspiration can be considered for a large, tense, or reaccumulating infected bursa, particularly when source control is incomplete, but persistent loculation or failure to improve requires orthopedic or surgical review. Incision, drainage, bursectomy, or other operative management is reserved for selected refractory or complicated cases.

Reassess within a short interval, often 24 to 48 hours, because superficial infection can progress despite an initially reassuring appearance. Improvement in pain, erythema, swelling, and function matters more than normalization of inflammatory markers. Duration of antibiotics is individualized to clinical response, culture results, host factors, and whether operative source control was required.

Epidemiology / Risk Factors

• Olecranon bursitis is associated with repetitive elbow pressure and minor trauma, while prepatellar bursitis is associated with frequent kneeling.
• Superficial skin breaks can inoculate the bursa directly.
• Diabetes, chronic kidney disease, alcohol use disorder, immunosuppression, and gout increase susceptibility or complicate recovery.
• Most septic cases are caused by S. aureus, with streptococci accounting for a smaller proportion.

Investigations

Disposition

Pharmacology

Prognosis / Complications

• Most uncomplicated septic bursitis resolves with appropriate antibiotics and pressure avoidance.
• Delayed treatment can lead to spreading cellulitis, recurrent infection, chronic drainage, or rarely osteomyelitis.
• Recurrence is more likely when repetitive trauma, gout, or an occupational exposure is not addressed.
• Surgical treatment is uncommon but can be effective for chronic or refractory infection.

Patient Education / Counseling

• Explain the difference between infection of the bursa and infection inside the joint, including why worsening motion is concerning.
• Protect the area from leaning or kneeling and avoid squeezing or self-draining the swelling.
• Take antibiotics exactly as directed and attend early reassessment even if symptoms begin to improve.
• Return urgently for fever, rapidly spreading redness, severe joint pain, new inability to move the joint, weakness, or systemic illness.
• After recovery, discuss protective padding and management of gout or other recurrence risks.

Notes

The diagnostic problem in superficial bursitis is not solved by redness alone. Both sterile inflammatory bursitis and septic bursitis can be warm and erythematous. The combination of clinical context, preserved joint motion, ultrasound findings, and fluid analysis when needed is more useful than any isolated sign.

Avoid automatic prolonged therapy. Once culture results and clinical response are available, narrow antibiotics and determine duration according to severity and source control. Persistent swelling after infection has improved can reflect residual inflammation rather than ongoing bacterial disease, so treatment should follow the whole clinical picture.

Recurrent “septic bursitis” should prompt a fresh diagnostic review. Gout, rheumatoid nodules, foreign body, chronic pressure, and atypical infection can mimic or predispose to repeated episodes. Addressing the cause is often as important as selecting another antibiotic.

References

1. AAFP: Common Superficial Bursitis — Link
2. IDSA Skin and Soft Tissue Infection Guideline — Link
3. AAOS OrthoInfo: Elbow Olecranon Bursitis — Link